Since we found that CTGF is elevated in invasive breast tumors, induces EMT, facilitates tumor growth and metastasis via remodeling collagen I fibers, we first attempted to find known drugs to inhibit the production of CTGF. This evidence concerns the gene CCN2 and breast neoplasm.